Whole-genome CRISPR screening identifies N-glycosylation as an essential pathway and a potential novel therapeutic target in CALR-mutant MPN (Whole Genome CRISPR Screen).
Ontology highlight
ABSTRACT: Whole-genome CRISPR screening identifies N-glycosylation as an essential pathway and a potential novel therapeutic target in CALR-mutant MPN (Whole Genome CRISPR Screen).
PROVIDER: PRJNA840899 | ENA |
REPOSITORIES: ENA
ACCESS DATA